101628: Drug Abuse Treatment Evidence: Collection II (NIDA Notes)

About the Course:

This course is based on three NIDA Notes articles. NIDA Notes is a large collection of brief, relevant articles focusing on current drug abuse treatment evidence.

The article Medications Development Division Nurtures the Creation of New Addiction Treatments centers around how Congress mandated NIDA to promote the development of medications “to treat the symptoms and disease of drug abuse” in conjunction with the Anti-Drug Abuse Act of 1988.

Community-Based Treatment Benefits Methamphetamine Abusers is about how methamphetamine abusers can achieve long-term abstinence with the help of standard community-based drug abuse treatment.

Bupropion Helps People With Schizophrenia Quit Smoking describes how the smoking-cessation aid bupropion is safe and effective for people with schizophrenia.

All three articles are contained in one PDF.

Journal/Publisher:

NIDA

Publication Date:

July 2006 and April 2006

Author

Lori Whitten

About the Author:

Lori Whitten is a NIDA Notes staff writer.

Recommended For:

This course is recommended for health care professionals, especially addiction counselors, psychologists, mental health counselors, social workers, and nurses who seek knowledge about new addiction treatments, how community-based treatment benefits methamphetamine abusers, and how bupropion helps people with schizophrenia quit smoking. It is appropriate for all levels of participants’ knowledge.

Course Objectives:

1. Describe how NIDA promoted the development of medications to treat the symptoms and disease of drug abuse.

2. Identify how community-based treatment benefits methamphetamine abusers.

3. Explain how bupropion helps people with schizophrenia to quit smoking.